Myopia outcome study of atropine in children: Two‐year result of daily 0.01% atropine in a European population
Myopia outcome study of atropine in children: Two‐year result of daily 0.01% atropine in a European population is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Myopia outcome study of atropine in children: Two‐year result of daily 0.01% atropine in a European population have?
Myopia outcome study of atropine in children: Two‐year result of daily 0.01% atropine in a European population has 67 citations in the OpenAlex counts ScholarIQ stores.
When was Myopia outcome study of atropine in children: Two‐year result of daily 0.01% atropine in a European population published?
Myopia outcome study of atropine in children: Two‐year result of daily 0.01% atropine in a European population has 2023 year in the ScholarIQ index.
What is the open-access status of Myopia outcome study of atropine in children: Two‐year result of daily 0.01% atropine in a European population?
Myopia outcome study of atropine in children: Two‐year result of daily 0.01% atropine in a European population has hybrid oa status in the ScholarIQ index.
What is the DOI of Myopia outcome study of atropine in children: Two‐year result of daily 0.01% atropine in a European population?
The DOI for Myopia outcome study of atropine in children: Two‐year result of daily 0.01% atropine in a European population is on the source record.
What is the PMID of Myopia outcome study of atropine in children: Two‐year result of daily 0.01% atropine in a European population?
The PMID for Myopia outcome study of atropine in children: Two‐year result of daily 0.01% atropine in a European population is on the source record.
What is the OpenAlex record for Myopia outcome study of atropine in children: Two‐year result of daily 0.01% atropine in a European population?
The OpenAlex for Myopia outcome study of atropine in children: Two‐year result of daily 0.01% atropine in a European population is on the source record.